Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2025 Rank: 40265
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 136 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40265 | 41197 |
| Total Cites | 697 | 783 |
| H-index | 14 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 50 | 50 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 118 | 118 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 168 | 173 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 660 | 724 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.08 |
| Self-Citation Percentage |
10.98%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2024 Rank: 42829
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 135 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42829 | 43759 |
| Total Cites | 674 | 807 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 48 | 48 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 88 | 90 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 148 | 156 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 622 | 713 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.13 |
| Self-Citation Percentage |
16.48%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2023 Rank: 33435
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 106 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33435 | 34469 |
| Total Cites | 831 | 930 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 56 | 56 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 116 | 116 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 183 | 188 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 779 | 858 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
10.65%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2022 Rank: 26752
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 83 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26752 | 29773 |
| Total Cites | 904 | 1039 |
| H-index | 17 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 54 | 54 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 127 | 129 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 188 | 194 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 853 | 956 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.09 |
| Self-Citation Percentage |
12.99%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2021 Rank: 29585
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 88 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29585 | 30634 |
| Total Cites | 1251 | 1463 |
| H-index | 20 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 67 | 68 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 180 | 184 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 281 | 298 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1161 | 1325 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
14.49%
|
|
Guha, Rajarshi
National Center for Advancing Translational Sciences,
United States
2020 Rank: 35235
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 105 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35235 | 33254 |
| Total Cites | 878 | 1074 |
| H-index | 16 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 46 | 47 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 133 | 142 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 207 | 225 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 798 | 946 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
18.25%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.